St.

Mary’s College
Bachelor of Science in Nursing
DRUG STUDY
Name of Patient: Attending Physician:
Age/Gender: Clinical Area/Agency
Chief Complaint: Submitted to:
Diagnosis:
Date Generic Brand Classification Indication Mechanism Dosage & Time Adverse Nursing Student’s CI’
Name Name of Action Frequency Given Reaction Consideration Sign Sign
10/11/19 Etoposide Etopophos Topoisomerase/ Refractory Inhibits 50 to 100mg CNS: Monitor CBC.
antineoplastics testicular cancer topoisomerase daily IV on 5 Peripheral Watch for
in combination II enzyme, consecutive neuropathy, evidence of
with other causing days 1, 3 CV: bone marrow
chemotherapeutic inability to and 5 every hypotension suppression
agents repair DNA 3 to 4 weeks GI: which can lead
strand breaks for three or Anorexia, to infection or
which leads to four courses diarrhea bleeding.
cell death. of therapy
Diagnosis:

Diagnosis: